Status:

COMPLETED

Health Literacy, Rational Drug Use, and Cyberchondria in Rheumatic Diseases

Lead Sponsor:

Gulseren Demir Karakilic

Conditions:

Rheumatoid Arthritis

Health Literacy

Eligibility:

All Genders

18-65 years

Brief Summary

Purpose: This study aimed to evaluate rational drug use (RDU), health literacy (HL), and cyberchondria levels among individuals diagnosed with inflammatory rheumatic diseases, and to investigate the f...

Detailed Description

Patient And Methods Study Design This prospective cross-sectional investigation was conducted from December 2024 to May 2025, involving both patient and control cohorts. Prior to enrollment, all parti...

Eligibility Criteria

Inclusion

  • Obtained approval from the local ethics committee. Provided informed consent to participate. Aged 18 to 65 years. Possessed intact cognitive functions. Literate. For the Rheumatoid Arthritis (RA) group: Met the 2010 ACR criteria for Rheumatoid Arthritis.
  • For the Ankylosing Spondylitis (AS) group: Met the Modified New York criteria. For the Psoriatic Arthritis (PsA) group: Met the Classification of Psoriatic Arthritis (CASPAR) criteria.
  • For the Knee Osteoarthritis (KOA) control group:
  • Visited the Physical Medicine and Rehabilitation clinic due to knee pain lasting six months or longer.
  • Diagnosed with knee osteoarthritis. Matched the patient group in terms of age and gender. Demonstrated adequate cognitive abilities. Possessed literacy skills.
  • For the Healthy control group:
  • Same age and gender as the patient group. Had good cognitive functions. Literate. Had no disease or complaints.

Exclusion

  • Under the age of 18 or over the age of 65. Any condition that could impair communication. Refusal to participate in the study. Not possessing digital devices such as a smartphone or computer, or lacking internet access.
  • Illiterate.

Key Trial Info

Start Date :

November 22 2024

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

May 20 2025

Estimated Enrollment :

228 Patients enrolled

Trial Details

Trial ID

NCT06993935

Start Date

November 22 2024

End Date

May 20 2025

Last Update

June 15 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Yozgat Bozok University

Yozgat, Yozgat, Turkey (Türkiye), 66100